Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease

被引:124
|
作者
Wong, BWC [1 ]
Wong, D [1 ]
McManus, BM [1 ]
机构
[1] Univ British Columbia, St Pauls Hosp, Dept Pathol & Lab Med, ICAPTURE Ctr,McDonald Res Labs, Vancouver, BC V6Z 1Y6, Canada
基金
加拿大健康研究院;
关键词
fractalkine; CX3CR1; atherosclerosis; diabetes mellitus; transplant vascular disease; chemokines;
D O I
10.1016/S1054-8807(02)00111-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Fractalkine is a novel chemokine that mediates both firm adhesion of leukocytes to the endothelium via CX3CR1 and leukocyte transmigration out of the bloodstream. Fractalkine has recently been shown to play a role in the pathogenesis of acute organ rejection. Since its expression is regulated by inflammatory agents such as LPS, IL-1, and TNF-alpha, fractalkine involvement in atherosclerosis and transplant vascular disease (TVD) is of particular interest. In this study, we characterized the presence of fractalkine and its receptor CX3CR1 in human coronary arteries from normal, atherosclerotic, diabetic, and TVD settings. Method: Polyclonal rabbit antibodies were used to immunostain human fractalkine and CX3CR1 to localize their presence in transverse sections of the proximal left anterior descending and/or right coronary arteries. Slides were scored in a blinded fashion for intensity of staining (0 to 4+) and for localization in vessel walls. Results: Normal coronary arteries showed no fractalkine staining. In atherosclerotic coronary arteries, staining was localized to the intima, media, and adventitia. Within the media, fractalkine expression was seen in macrophages, foam cells, and smooth muscle cells (SMCs). Diabetic vessels showed similar staining patterns to atherosclerotic coronaries, with much stronger staining in the deep intima. Transplanted coronaries showed staining in the endothelium, intima, and adventitia in early disease, and intimal, medial, and adventitial staining in late disease. CX3CR1 staining was seen in the coronary arteries of all cases, with specific localization to regions with fractalkine staining. Conclusion: The distinctive staining patterns in native atherosclerosis, diabetes mellitus with atherosclerosis, and TVD indicate that the expression of fractalkine and CX3CR1 may be important in the pathogenesis of these diseases. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:332 / 338
页数:7
相关论文
共 50 条
  • [21] Hydrogen Sulfide Inhibits the Development of Atherosclerosis with Suppressing CX3CR1 and CX3CL1 Expression
    Zhang, Huili
    Guo, Changfa
    Wu, Duojiao
    Zhang, Alian
    Gu, Ting
    Wang, Liansheng
    Wang, Changqian
    PLOS ONE, 2012, 7 (07):
  • [22] The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
    Pawelec, Paulina
    Ziemka-Nalecz, Malgorzata
    Sypecka, Joanna
    Zalewska, Teresa
    CELLS, 2020, 9 (10) : 1 - 17
  • [23] Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease
    von Vietinghoff, Sibylle
    Kurts, Christian
    CELL AND TISSUE RESEARCH, 2021, 385 (02) : 335 - 344
  • [24] Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
    Limatola, Cristina
    Ransohoff, Richard M.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [25] Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease
    Sibylle von Vietinghoff
    Christian Kurts
    Cell and Tissue Research, 2021, 385 : 335 - 344
  • [26] Fractalkine (CX3CL1) in patients with stable coronary artery disease (CAD) with and without diabetes mellitus
    Njerve, I. U.
    Pettersen, A. A.
    Opstad, T. B.
    Bratseth, V.
    Arnesen, H.
    Seljeflot, I.
    CARDIOVASCULAR RESEARCH, 2012, 93 : S78 - S79
  • [27] Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
    Szukiewicz, Dariusz
    Kochanowski, Jan
    Pyzlak, Michal
    Szewczyk, Grzegorz
    Stangret, Aleksandra
    Mittal, Tarun Kumar
    MEDIATORS OF INFLAMMATION, 2013, 2013
  • [28] Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1)
    Lucas, AD
    Bursill, C
    Guzik, TJ
    Sadowski, J
    Channon, KM
    Greaves, DR
    CIRCULATION, 2003, 108 (20) : 2498 - 2504
  • [29] Fractalkine and Its Receptor (CX3CR1) in Patients with Stable Coronary Artery Disease and Diabetes Mellitus
    Njerve, Ida Unhammer
    Pettersen, Alf Age
    Opstad, Trine Baur
    Arnesen, Harald
    Seljeflot, Ingebjorg
    METABOLIC SYNDROME AND RELATED DISORDERS, 2012, 10 (06) : 400 - 406
  • [30] Fractalkine, (CX3CL1)/fractalkine receptor (CX3CR1) interactions influence motor and sensory recovery after spinal cord injury
    McDaniel, EE
    Popovich, PG
    JOURNAL OF NEUROTRAUMA, 2005, 22 (10) : 1219 - 1219